Revenue growth re-accelerated to 58.0% in 2026Q3 with gross margin expanding to 85.2%, yet the operating margin of just 0.4% and a 2025Q4 net loss of $133.7M suggest profitability remains fragile.
Glaukos Corporation (GKOS) annual income statement — 14-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|
| Sales/Revenue | 690.33M | 507.44M | 383.48M | 314.71M | 282.86M | 294.01M | 224.96M | 236.98M | 181.28M | 159.25M | 114.4M | 71.7M | 45.59M | 20.95M | 2.43M |
| Revenue Growth % | 46.94% | 32.33% | 21.85% | 11.26% | -3.79% | 30.7% | -5.07% | 30.73% | 13.83% | 39.21% | 59.55% | 57.28% | 117.64% | 762.33% | - |
| Cost of Goods Sold | 130.29M | 114.23M | 94.03M | 75.58M | 68.98M | 66.63M | 91.72M | 38.59M | 25.07M | 21.05M | 16.18M | 12.99M | 11.42M | 2.54M | 1.66M |
| COGS % of Revenue | - | 22.51% | 24.52% | 24.01% | 24.39% | 22.66% | 40.77% | 16.28% | 13.83% | 13.22% | 14.14% | 18.11% | 25.05% | 12.1% | 68.14% |
| Gross Profit | 560.04M | 393.22M | 289.45M | 239.14M | 213.88M | 227.38M | 133.24M | 198.4M | 156.2M | 138.2M | 98.22M | 58.71M | 34.17M | 18.41M | 774K |
| Gross Margin % | 81.13% | 77.49% | 75.48% | 75.99% | 75.61% | 77.34% | 59.23% | 83.72% | 86.17% | 86.78% | 85.86% | 81.89% | 74.95% | 87.9% | 31.86% |
| Gross Profit Growth % | - | 35.85% | 21.04% | 11.81% | -5.94% | 70.66% | -32.84% | 27.01% | 13.02% | 40.71% | 67.29% | 71.83% | 85.59% | 2278.68% | - |
| Operating Expenses | 623.34M | 479.95M | 411.82M | 367.84M | 296.2M | 260.26M | 256.79M | 248.69M | 169.21M | 140.49M | 93.98M | 69.01M | 47.34M | 32.61M | 22.57M |
| OpEx % of Revenue | - | 94.58% | 107.39% | 116.88% | 104.71% | 88.52% | 114.15% | 104.94% | 93.34% | 88.21% | 82.15% | 96.25% | 103.85% | 155.68% | 928.98% |
| Selling, General & Admin | 434.65M | 329.33M | 262.85M | 224.07M | 192.93M | 179.26M | 171.4M | 176.63M | 119.53M | 96.26M | 64.76M | 43.96M | 28.14M | 17.1M | 9.57M |
| SG&A % of Revenue | - | 64.9% | 68.54% | 71.2% | 68.2% | 60.97% | 76.19% | 74.53% | 65.94% | 60.44% | 56.61% | 61.31% | 61.72% | 81.63% | 394.11% |
| Research & Development | 187.19M | 150.61M | 136.43M | 138.77M | 123.27M | 101M | 85.39M | 68.31M | 49.68M | 38.91M | 29.22M | 25.05M | 19.2M | 15.51M | 13.3M |
| R&D % of Revenue | - | 29.68% | 35.58% | 44.09% | 43.58% | 34.35% | 37.96% | 28.82% | 27.4% | 24.43% | 25.55% | 34.93% | 42.13% | 74.05% | 547.51% |
| Other Operating Expenses | 1000K | 0 | 12.55M | 5M | -20M | -20M | 0 | 3.75M | 0 | 5.32M | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -63.3M | -86.73M | -122.37M | -128.7M | -82.31M | -32.87M | -123.55M | -50.29M | -13M | -2.28M | 4.24M | -10.3M | -13.17M | -14.2M | -22.1M |
| Operating Margin % | -9.17% | -17.09% | -31.91% | -40.89% | -29.1% | -11.18% | -54.92% | -21.22% | -7.17% | -1.43% | 3.71% | -14.36% | -28.89% | -67.78% | -909.76% |
| Operating Income Growth % | - | 29.12% | 4.92% | -56.35% | -150.4% | 73.39% | -145.67% | -286.8% | -470.01% | -153.78% | 141.19% | 21.83% | 7.23% | 35.75% | - |
| EBITDA | -18.09M | -44.39M | -82.44M | -90.72M | -46.37M | 1.55M | -88.94M | -40.43M | -6.74M | 3.2M | 8.96M | -6.03M | -8.94M | -13.04M | -21.46M |
| EBITDA Margin % | -2.62% | -8.75% | -21.5% | -28.83% | -16.39% | 0.53% | -39.54% | -17.06% | -3.72% | 2.01% | 7.83% | -8.41% | -19.61% | -62.26% | -883.49% |
| EBITDA Growth % | 63.43% | 46.16% | 9.12% | -95.66% | -3093.35% | 101.74% | -119.99% | -500.01% | -310.5% | -64.29% | 248.66% | 32.56% | 31.45% | 39.23% | - |
| D&A (Non-Cash Add-back) | 45.2M | 42.34M | 39.92M | 37.98M | 35.95M | 34.42M | 34.61M | 9.86M | 6.26M | 5.48M | 4.72M | 4.27M | 4.23M | 1.16M | 638K |
| EBIT | -169.2M | -188.41M | -135.56M | -120.09M | -84.71M | -35.9M | -118.2M | -47.47M | -12.37M | 1K | 4.24M | -37.23M | -13.16M | -13.91M | -22.1M |
| Net Interest Income | 4.9M | 6.08M | 1.06M | -4.47M | -11.35M | -12.08M | -11.74M | 604K | 2.25M | 1.38M | 281K | -980K | -873K | -294K | 0 |
| Interest Income | 9.71M | 10.71M | 11.11M | 9.16M | 2.38M | 1.29M | 2.38M | 3.17M | 2.25M | 1.38M | 889K | 82K | 3K | 13K | 228K |
| Interest Expense | 4.82M | 4.63M | 10.04M | 13.63M | 13.72M | 13.37M | 14.12M | 2.56M | 0 | 0 | 608K | 1.06M | 876K | 307K | 0 |
| Other Income/Expense | -111.22M | -106.31M | -23.23M | -5.03M | -16.12M | -16.39M | -8.76M | 256K | 634K | 2.28M | 324K | -27.99M | -868K | -23K | 79K |
| Pretax Income | -174.51M | -193.04M | -145.6M | -133.73M | -98.43M | -49.27M | -132.31M | -50.04M | -12.37M | 1K | 4.57M | -38.29M | -14.04M | -14.22M | -22.02M |
| Pretax Margin % | -25.28% | -38.04% | -37.97% | -42.49% | -34.8% | -16.76% | -58.82% | -21.11% | -6.82% | 0% | 3.99% | -53.4% | -30.8% | -67.89% | -906.5% |
| Income Tax | -4.72M | -5.35M | 771K | 934K | 766K | 326K | -11.97M | -65.46M | 583K | 93K | 43K | 33K | 18K | 6K | 3K |
| Effective Tax Rate % | 2.7% | 2.77% | -0.53% | -0.7% | -0.78% | -0.66% | 9.04% | 130.83% | -4.71% | 9300% | 0.94% | -0.09% | -0.13% | -0.04% | -0.01% |
| Net Income | -169.8M | -187.69M | -146.37M | -134.66M | -99.19M | -49.59M | -120.35M | 15.42M | -12.95M | -92K | 4.52M | -37.24M | -12.13M | -12.64M | -19.33M |
| Net Margin % | -24.6% | -36.99% | -38.17% | -42.79% | -35.07% | -16.87% | -53.5% | 6.51% | -7.14% | -0.06% | 3.95% | -51.94% | -26.6% | -60.34% | -795.84% |
| Net Income Growth % | -93.8% | -28.23% | -8.7% | -35.75% | -100.02% | 58.79% | -880.26% | 219.1% | -13977.17% | -102.03% | 112.14% | -207.12% | 4.06% | 34.62% | - |
| Net Income (Continuing) | -169.8M | -187.69M | -146.37M | -134.66M | -99.19M | -49.59M | -120.35M | 15.42M | -12.95M | -92K | 4.52M | -38.32M | -14.06M | -14.23M | -19.33M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.61M | -7.74M | -6.16M |
| EPS (Diluted) | -2.77 | -3.28 | -2.77 | -2.78 | -2.09 | -1.07 | -2.70 | 0.37 | -0.37 | -0.00 | 0.12 | -2.13 | -0.49 | -0.51 | -9.73 |
| EPS Growth % | -90.91% | -18.41% | 0.36% | -33.01% | -95.33% | 60.37% | -829.73% | 200% | - | -102.25% | 105.63% | -334.69% | 3.92% | 94.76% | - |
| EPS (Basic) | - | -3.28 | -2.77 | -2.78 | -2.09 | -1.07 | -2.70 | 0.41 | -0.37 | -0.00 | 0.14 | -2.13 | -0.49 | -0.51 | -9.73 |
| Diluted Shares Outstanding | 61.2M | 57.19M | 52.76M | 48.43M | 47.44M | 46.42M | 44.5M | 41.15M | 35.32M | 34.38M | 36.46M | 17.47M | 24.89M | 24.89M | 1.99M |
| Basic Shares Outstanding | 59.1M | 57.19M | 52.76M | 48.43M | 47.44M | 46.42M | 44.5M | 37.35M | 35M | 34.38M | 32.93M | 17.47M | 24.89M | 24.89M | 1.99M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying GKOS stock.
For fiscal year 2025, Glaukos Corporation (GKOS) reported total revenue of $507.4M. This represents a 20791.0% increase compared to $2.4M in 2012.
Glaukos Corporation (GKOS) reported a net loss of $187.7M for the fiscal year ending 2025.
Glaukos Corporation (GKOS) reported an operating income of $-86.7M, resulting in an operating profit margin of -17.1%. This margin reflects the operational efficiency of the business before interest and taxes.
Glaukos Corporation (GKOS) generated $393.2M in gross profit for the year, representing a gross profit margin of 77.5%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Operating margin barely positive
Metrics are mathematically derived from official filings.
Revenue Re-Accelerating From Depressed Base
Based on reported figures, GKOS revenue grew 58.0% year over year to $211.0M in 2026Q3, up from 24.6% in 2025Q1, suggesting a sharp re-acceleration over the past several quarters.
The climb in year-over-year growth from roughly 25% to 58% across seven quarters indicates demand and commercial execution improved materially. Because comparison bases were weak in earlier periods, investors should separate sustained volume-driven growth from favorable base effects before extrapolating the current rate. The supplied data does not isolate pricing, volume, or inorganic contributions, so durability remains an open question warranting further investigation.
Gross Margin Expansion Underpins Operating Path
As reported in financial statements, GKOS gross margin expanded from 72.9% in 2024Q4 to 85.2% in 2026Q3, a meaningful structural improvement in unit economics.
Gross margin has risen across most recent quarters, which may reflect manufacturing scale, favorable product mix, or pricing realization, though the figures alone do not attribute the gain. Relative to peers, GKOS now sits near the top of the gross margin range alongside INSP at 85.4%. Investors should monitor whether this level holds as revenue scales, since it is the primary lever underpinning any path to sustained operating profitability.
Operating Leverage Emerging But Unproven
Based on GKOS's reported figures, operating income turned positive at $0.8M in 2026Q3 after losses of up to $30.0M in 2024Q2, indicating early operating leverage that has not yet proven durable.
Operating income improved sharply as revenue grew faster than SG&A, which rose from $64.0M to $130.9M over the period, though at a slower relative pace than gross profit. The 0.4% operating margin is barely positive, leaving little cushion against a revenue shortfall or cost shock. Whether this inflection persists depends on continued SG&A discipline, which a single positive quarter does not yet establish.
Net Income Flattered by Single Quarter
According to reported filings, GKOS posted $2.0M of net income in 2026Q3 against consistent losses in prior quarters, while the 2025Q4 net loss of $133.7M appears to reflect a large non-operating or discrete item.
The gap between the 2025Q4 operating loss of $27.0M and net loss of $133.7M suggests substantial non-operating charges that the supplied data does not itemize, so the cause warrants review in the filings. The 2026Q3 profit is thin and operating income is near breakeven, so it should not be treated as evidence of sustained earnings power. Stock-based compensation of $17.8M in the latest quarter is material relative to operating income when judging true economic profitability.
SG&A Carries Bulk of Cost Base
Based on GKOS's reported figures, SG&A of $130.9M in 2026Q3 represents roughly 62% of revenue, making it the dominant cost line ahead of R&D at $48.1M.
SG&A is the largest operating expense and has grown in step with revenue, limiting how much of the gross margin gain reaches the operating line. R&D spending of $48.1M remains substantial at roughly 23% of revenue, consistent with a continued investment posture. Further operating margin expansion appears to depend on SG&A growing more slowly than revenue over coming periods.
Margin Gains Vulnerable to Reversal
Based on reported figures, GKOS's 2026Q3 operating margin of 0.4% followed a -9.3% quarter in 2026Q2, so a single profitable period may not represent a durable turn.
The 2026Q3 result depends on a sharp swing in SG&A and gross profit within one quarter, and a modest revenue slowdown or cost rebound could return the company to operating losses. Revenue growth of 58% is well above the trailing trend and may reflect base effects that reverse, which would compress the reported growth narrative. Investors should weigh whether the high gross margin is sustainable against the recent history of losses before treating the inflection as established.